Literature DB >> 7654488

Prolonged half-life of verapamil in a case of overdose: implications for therapy.

C D Buckley1, J K Aronson.   

Abstract

After an overdose of verapamil (2.4 g) in a 59-year-old man the apparent half-life of verapamil was prolonged (15 h). The most likely mechanism is rate-limiting absorption, although changes in clearance and volume of distribution may contribute. As the elimination half-life of verapamil is increased in overdose, therapy may have to be continued for longer than expected. Moreover since the half-life of absorption of verapamil in overdose may be prolonged, activated charcoal should be given in repeated doses, even if an ordinary-release formulation has been taken.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7654488      PMCID: PMC1365082          DOI: 10.1111/j.1365-2125.1995.tb05729.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

Review 1.  [Acute verapamil poisoning. 6 cases. Review of the literature].

Authors:  P Sauder; J Kopferschmitt; M Dahlet; L Tritsch; F Flesch; P Siard; J M Mantz; A Jaeger
Journal:  J Toxicol Clin Exp       Date:  1990 Jul-Aug

2.  Severe verapamil (sustained-release) overdose.

Authors:  S E Krick; J G Gums; K Grauer; G R Cooper
Journal:  DICP       Date:  1990 Jul-Aug

Review 3.  Massive verapamil ingestion: a report of two cases and a review of the literature.

Authors:  B Z Horowitz; K J Rhee
Journal:  Am J Emerg Med       Date:  1989-11       Impact factor: 2.469

4.  Lack of response to intravenous calcium in severe verapamil poisoning.

Authors:  B J Crump; D W Holt; J A Vale
Journal:  Lancet       Date:  1982-10-23       Impact factor: 79.321

5.  Treating overdose with calcium channel blockers.

Authors:  J Kenny
Journal:  BMJ       Date:  1994-04-16

Review 6.  Extracorporeal bypass for the treatment of verapamil poisoning.

Authors:  W G Hendren; R S Schieber; L K Garrettson
Journal:  Ann Emerg Med       Date:  1989-09       Impact factor: 5.721

Review 7.  Clinical pharmacokinetics of verapamil.

Authors:  S R Hamann; R A Blouin; R G McAllister
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

8.  Reduced verapamil clearance during long-term oral administration.

Authors:  D G Shand; S C Hammill; L Aanonsen; E L Pritchett
Journal:  Clin Pharmacol Ther       Date:  1981-11       Impact factor: 6.875

9.  Verapamil kinetics in normal subjects and patients with coronary artery spasm.

Authors:  S B Freedman; D R Richmond; J J Ashley; D T Kelly
Journal:  Clin Pharmacol Ther       Date:  1981-11       Impact factor: 6.875

10.  Verapamil disposition kinetics in chronic atrial fibrillation.

Authors:  R E Kates; D L Keefe; J Schwartz; S Harapat; E B Kirsten; D C Harrison
Journal:  Clin Pharmacol Ther       Date:  1981-07       Impact factor: 6.875

View more
  4 in total

1.  Anecdotes as evidence.

Authors:  Jeffrey K Aronson
Journal:  BMJ       Date:  2003-06-21

Review 2.  Management of calcium channel antagonist overdose.

Authors:  Steven D Salhanick; Michael W Shannon
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  [Seizure and non-cardiogenic pulmonary edema after intoxication].

Authors:  M Sawatzki; O Kummer; S Krähenbühl; M Siegemund
Journal:  Internist (Berl)       Date:  2010-04       Impact factor: 0.743

4.  Heart insufficiency after combination of verapamil and metoprolol: A fatal case report and literature review.

Authors:  Eva A Saedder; Asser Hedegård Thomsen; Jørgen Bo Hasselstrøm; Jakob Ross Jornil
Journal:  Clin Case Rep       Date:  2019-09-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.